Document is current
Any future updates will be listed below
-
Authors
Rai, Bhim B. https://orcid.org/0000-0003-0748-4581
Sabeti, Faran https://orcid.org/0000-0001-9187-7569
van Kleef, Joshua P. https://orcid.org/0000-0003-2167-0348
Carle, Corinne F. https://orcid.org/0000-0002-3309-9073
Rohan, Emilie M. F. https://orcid.org/0000-0003-0402-3296
Essex, Rohan W. https://orcid.org/0000-0001-5323-0334
Barry, Richard C. https://orcid.org/0000-0002-0566-6667
Maddess, Ted https://orcid.org/0000-0003-4591-3658
-
Funding
Funding for this research was provided by:
Rebecca L. Cooper Medical Research Foundation (PG2018040)
MRFF Biotechnology Bridge grant (BTBR100196)
- License Information
-
More Information
Article History
Received: 20 September 2023
Revised: 1 February 2024
Accepted: 7 March 2024
First Online: 14 March 2024
Declarations
:
: This study was approved by the ACT Health Human Research Ethics Committee (ETH 7.07.667) and Australian National University Human Ethics Committee (2010/194).
: T Maddess, JP van Kleef, and CF Carle have received funding from Konan Medical USA, the manufacturer of the ObjectiveFIELD Analyser (OFA), and could earn royalty income from the sale of the OFA due to patents assigned to Konan. The other authors have nothing to declare.
